Clinical Trial Update: A Dose-finding Study of Silodosin in Patients With Urinary Calculi [Phase 2]

View source ↗

Summary

This update reports the results of a Phase 2 dose-finding study of silodosin in patients with urinary calculi (urinary stones). The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Calculi

Drugs mentioned

• Silodosin (Silodosin)

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Urinary Calculus | Phase 2 | Status: COMPLETED